Market closedNon-fractional
Quanterix/QTRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Quanterix
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.
Ticker
QTRX
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Billerica, United States
Employees
441
Website
www.quanterix.com
Quanterix Metrics
BasicAdvanced
$584M
Market cap
-
P/E ratio
-$0.96
EPS
1.41
Beta
-
Dividend rate
Price and volume
Market cap
$584M
Beta
1.41
Financial strength
Current ratio
11.376
Quick ratio
10.31
Long term debt to equity
10.568
Total debt to equity
11.847
Management effectiveness
Return on assets (TTM)
-7.30%
Return on equity (TTM)
-10.39%
Valuation
Price to revenue (TTM)
4.581
Price to book
1.72
Price to tangible book (TTM)
1.74
Price to free cash flow (TTM)
-17.114
Growth
Revenue change (TTM)
20.64%
Earnings per share change (TTM)
-57.89%
3-year revenue growth (CAGR)
8.78%
3-year earnings per share growth (CAGR)
-0.26%
What the Analysts think about Quanterix
Analyst Ratings
Majority rating from 5 analysts.
Quanterix Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$32M
1.59%
Net income
-$10M
-19.35%
Profit margin
-31.25%
-20.60%
Quanterix Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.16
-$0.21
-$0.33
-$0.26
-
Expected
-$0.38
-$0.37
-$0.32
-$0.32
-$0.25
Surprise
-57.62%
-43.24%
3.77%
-17.46%
-
Quanterix News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Quanterix stock?
Quanterix (QTRX) has a market cap of $584M as of July 27, 2024.
What is the P/E ratio for Quanterix stock?
The price to earnings (P/E) ratio for Quanterix (QTRX) stock is 0 as of July 27, 2024.
Does Quanterix stock pay dividends?
No, Quanterix (QTRX) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Quanterix dividend payment date?
Quanterix (QTRX) stock does not pay dividends to its shareholders.
What is the beta indicator for Quanterix?
Quanterix (QTRX) has a beta rating of 1.41. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Quanterix stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.